Fatimunnisa Qadri

Title: Innovations in Cosmetic Dermatology by Fatimunnisa Qadri

Introduction

Fatimunnisa Qadri is an accomplished inventor based in Berlin, Germany. She has made significant contributions to the field of cosmetic dermatology, particularly in the modulation of pigmentation. Her innovative approach combines scientific research with practical applications in skincare.

Latest Patents

Fatimunnisa holds a patent for her work titled "Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation." This cosmetic method involves administering a modulator of angiotensin-converting enzyme 2 (ACE2 modulator) to a subject. The ACE2 modulator can be an inhibitor, which increases pigmentation, or an activator, which decreases pigmentation. Additionally, her research addresses the treatment of inflammatory skin diseases through the inhibition of ACE2.

Career Highlights

Fatimunnisa Qadri is affiliated with the Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft. Her work has garnered attention for its potential applications in enhancing skin health and appearance. She has dedicated her career to exploring the intersection of molecular medicine and cosmetic science.

Collaborations

Fatimunnisa collaborates with notable colleagues, including Michael Bader and Mihail Todiras. Their combined expertise contributes to the advancement of research in the field of molecular medicine and dermatology.

Conclusion

Fatimunnisa Qadri's innovative work in cosmetic dermatology exemplifies the impact of scientific research on everyday life. Her contributions to pigmentation modulation and skin disease treatment highlight the importance of continued innovation in this field.